Welcome

Welcome to the website for Transregional Collaborative Research Center (CRC) SFB TR-128 Initiating/effector versus regulatory mechanisms in Multiple Sclerosis – progress towards tackling the disease. On this site you will find general information regarding the CRC as well as more specific information about its individual research projects.

Multiple Sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system (CNS) in the western world and it leads to devastating disability in young adults, with only limited treatment options currently available. The socioeconomic burden of this disease is tremendous, since healthcare costs are very high and it affects decisions young patients must make for the rest of their lives. Findings in patients are a complex composite of inflammation (with demyelination, remyelination, axonal/neuronal damage) typically in subcortical, but also cortical, disseminated lesions as well as neurodegeneration. Remissions of clinical relapses point to repair capacities of the CNS, which exhibits strong interindividual and course dependent differences.

Heinz Wiendl
Spokesperson

Frauke Zipp
Co-Spokesperson

News

Thu, 20/04/2017
International Symposium 2017: SFB Junior Researchers Present their Projects
Muenster. For the second time, the Cluster of Excellence “Cells in Motion” hosts an international symposium. In interdisciplinary sessions and talks, international top class scientists will present their current research questions and findings. The list of speakers comprises experts from chemistry, mathematics, physics, biology and medicine, going beyond the boundaries of specialised fields and reflecting […]...more
Thu, 20/04/2017
“Cardiac regeneration: from zebrafish to mammals”
Muenster. At the lecture series “Piomeers in Cell Dynamic and Imaging” international guests as well as scientists from the Cells-in-Motion Cluster of Excellence and the biomedical Collaborative Research Centres of the University of Münster present their most recent scientific advances in basic and translational research. In April, Felix Engel, Professor for Experimental Renal and Cardiovascular […]...more
Thu, 20/04/2017
Spotlight on Formyl Peptide Chemoattractant Receptors
Muenster. The CRC Breaking Barriers: Immune cells and pathogens at cell / matrix barriers cordially invites interested audience to attend its upcoming Jour-Fixe Meeting. SFB scientists Ursula Rescher and Volker Gerkewill talk about Formyl peptide chemoattractant receptors in leukocyte activation and trans-endothelial migration. When?: Monday, April 24, 1:00 PM Where?: Lecture Hall, Department of Dermatology, […]...more